メニエール病に対するMeniett® による中耳加圧療法の臨床的検討

概要

論文の詳細を見る
We investigated the efficiency of a micropressure pulse generator, Meniett® in controlling the symptoms of patients with intractable Menieres disease. Nine patients with intractable vertigo despite adequate medical treatment underwent the placement of a standard tympanostomy tube. Seven of these patients self-administered Meniett® three times a day because their vertigo symptoms were not improved by the placement of a standard tympanostomy tube only. The treatment periods with Meniett® ranged from 6 to 38 months with an average of 18.3 months, and the follow up periods ranged from 12 to 38 months with an average of 23.9 months. Five patients did respond to the device and it reduced the frequency and severity of their vertigo attacks, however 2 patients did not show adequate benefits. Two patients showed an improvement in hearing level after a follow-up of 12 months. In addition, there was no complication during the follow-up periods. These results suggest that Meniett® is effective and safe in controlling vestibular symptoms.